Pathological findings in central nervous system demyelination associated with infliximab

Background: Tumor necrosis factor alpha (TNF-alpha) inhibitors, such as infliximab, are commonly used to treat rheumatoid arthritis (RA) and other immune-mediated disorders. Objective: To determine whether infliximab-associated central nervous system (CNS) demyelination can be differentiated from mu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Multiple sclerosis 2020-08, Vol.26 (9), p.1124-1129
Hauptverfasser:	Kalinowska-Lyszczarz, Alicja, Fereidan-Esfahani, Mahboobeh, Guo, Yong, Lucchinetti, Claudia F, Tobin, W Oliver
Format:	Artikel
Sprache:	eng
Schlagworte:	Central nervous system Demyelination Immunotherapy Inflammation Infliximab Monoclonal antibodies Multiple sclerosis Nervous system Rheumatoid arthritis TNF inhibitors Tumor necrosis factor-TNF Tumor necrosis factor-α
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!